Talquetamab (Anti-CD3 & GPRC5D)
Gecertificeerd

Talquetamab (Anti-CD3 & GPRC5D)

Catalog #: C00890
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

CAS Number

2226212-40-2

Synonyms

JNJ-64407564

SKU

C00890-1mg

Target

CD markers

Applications

Transmembrane Transporters

Additionnal Information

Talquetamab is a bispecific humanized monoclonal antibody targeting human CD3 on T cells and the multiple myeloma-associated antigen G protein-coupled receptor family C group 5 member D (GPRC5D) on tumor cells. It redirects T cells to bind and attack GPRC5D-expressing tumor cells, inducing a potent cytotoxic T-lymphocyte (CTL) response. Talquetamab is approved by the U.S. Food and Drug Administration (FDA) for patients with relapsed/refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy, including a proteasome inhibitor (PI), an immunomodulatory drug (IMiD), and an anti-CD38 monoclonal antibody. MW: 144.6 KD.

Storage Conditions

-80°C (avoid freeze-thaw cycles)

Beschrijving

Talquetamab (Anti-CD3 & GPRC5D) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamTalquetamab (Anti-CD3 & GPRC5D)
Categorie
Beschikbare grootte1 mg
CatalogusnummerC00890